Sabinsa intellectual property strengthen with granting of two additional international patents
![Sabinsa intellectual property strengthen with granting of two additional international patents Sabinsa intellectual property strengthen with granting of two additional international patents](https://sami-sabinsagroup.com/media/tz_portfolio/article/cache/sabinsa-intellectual-property-strengthen-with-granting-of-two-additional-international-patents-842_L.jpg)
Sabinsa, the international ingredients company, has received notification that two additional patents have been granted.
The company’s Garcitrin® product is now protected by Japanese patent number 4205943 for "Bioavailable composition of natural and synthetic HCA." The hydroxycitric acid (HCA) has been uniquely combined with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits, the result is GarCitrin®. In GarCitrin®, garcinol enhances the biological action of HCA and also contributes antioxidant activity to the formulation. A 12-week, double blind clinical with over 40 patients statistically proved GarCitrin® is statistically more effective than HCA alone in: